Biohaven BHVN
NYSE BHVN
$15.69 -0.17 (-1.07%)
As of: Sep 4, 2026 · 3:59 PM EDT

Biohaven (BHVN) Retained Earnings (2022 - 2026)

Biohaven (BHVN) posted Retained Earnings of -$2.2 billion for Q1 2026, down 1241.88% sequentially from $194.0 million in Q4 2025, and down 41.32% YoY from -$3.8 billion in Q1 2025.

Analysis

Biohaven (BHVN) Retained Earnings (2022 - 2026) Analysis & Trends

Biohaven has reported Retained Earnings for 5 years, with the latest figure at -$2.2 billion in Q1 2026.

  • Quarterly Retained Earnings fell 41.32% year-over-year to -$2.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.2 billion (down 41.32% YoY) and the FY2025 annual result came in at $194.0 million, up 114.41% from the prior year.
  • Retained Earnings slipped to -$2.2 billion in Q1 2026 per BHVN's latest filing, from $194.0 million in the prior quarter.
  • Over five years, Retained Earnings peaked at $194.0 million in Q4 2025 and troughed at -$2.2 billion in Q1 2026.
  • A 5-year average of -$520.4 million and a median of $101000.0 in 2023 frame the typical range for Retained Earnings.
  • The sharpest annual moves came in 2023 and 2024: Retained Earnings slumped 175907.04% in 2023, then soared 41698.19% in 2024.
  • Over 5 years, Retained Earnings stood at $284000.0 in 2022, then plunged by 175907.04% to -$499.3 million in 2023, then slumped by 169.52% to -$1.3 billion in 2024, then surged by 114.41% to $194.0 million in 2025, then slumped by 1241.88% to -$2.2 billion in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered -$2.2 billion, $194.0 million, and $36000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 Biohaven 2.37 Bn 2.10 Bn - -2.35 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.35 Bn
Mar 31, 2026 -2.22 Bn
Dec 31, 2025 -2.08 Bn
Sep 30, 2025 -1.94 Bn
Jun 30, 2025 -1.77 Bn
Mar 31, 2025 -1.57 Bn
Dec 31, 2024 -1.35 Bn
Sep 30, 2024 -1.16 Bn
Jun 30, 2024 -998.57 Mn
Mar 31, 2024 -678.80 Mn
Dec 31, 2023 -499.29 Mn
Sep 30, 2023 -354.54 Mn
Jun 30, 2023 -251.96 Mn
Mar 31, 2023 -161.62 Mn
Dec 31, 2022 -91.12 Mn